Compounds > amoxicillin-potassium-clavulanate-combination

amoxicillin-potassium-clavulanate-combination and Focal-Infection

amoxicillin-potassium-clavulanate-combination has been researched along with Focal-Infection* in 1 studies

Trials

1 trial(s) available for amoxicillin-potassium-clavulanate-combination and Focal-Infection

Article	Year
[A clinico-laboratory assessment of the efficacy of an Augmentin suspension in treating children with suppurative-inflammatory diseases caused by opportunistic bacteria]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992, Volume: 37, Issue:9 Augmentin suspension (amoxycillin+clavulanic acid) was estimated in clinico-laboratory studies with respect to children suffering from pyoinflammatory diseases of various localization and its high efficacy was shown. Good and satisfactory results were recorded in 96.3 per cent of the cases in the treatment (monotherapy) and afterwards in the patients, adverse reactions such as nausea and vomiting being recorded only in 1 patient. The therapy with augmentin led to normalization of the microflora of the upper respiratory tract mucosa and a 1.5-fold increase in the neutrophil engulfment index. Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Bacterial Infections; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Drug Tolerance; Focal Infection; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Opportunistic Infections; Suspensions	1992

Article

Year

[A clinico-laboratory assessment of the efficacy of an Augmentin suspension in treating children with suppurative-inflammatory diseases caused by opportunistic bacteria].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992, Volume: 37, Issue:9

Augmentin suspension (amoxycillin+clavulanic acid) was estimated in clinico-laboratory studies with respect to children suffering from pyoinflammatory diseases of various localization and its high efficacy was shown. Good and satisfactory results were recorded in 96.3 per cent of the cases in the treatment (monotherapy) and afterwards in the patients, adverse reactions such as nausea and vomiting being recorded only in 1 patient. The therapy with augmentin led to normalization of the microflora of the upper respiratory tract mucosa and a 1.5-fold increase in the neutrophil engulfment index.

Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Bacterial Infections; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Drug Tolerance; Focal Infection; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Opportunistic Infections; Suspensions

1992